The idea of a peptide linked with exercise and ageing is easy to be curious about. I want the years ahead to include movement, adventures and energy for everyday life.
But before connecting that hope to MOTS-c, I want to know what researchers actually did. This series revisits studies from 2019, 2021 and June 2026; these are research dates, not a new treatment announcement.
First, what is MOTS-c?
MOTS-c is a short peptide encoded by mitochondrial DNA and studied for its role in metabolic signalling. The Nature Communications paper by Joseph C. Reynolds and colleagues was published on 20 January 2021. [1]
Calling it an “exercise peptide” can blur two very different questions: what happens naturally during exercise, and what happens when researchers give the peptide as an intervention?
The mice received MOTS-c; the men exercised
In one part of the study, mice of different ages were given MOTS-c and showed better physical performance under the tested conditions.
In another part, 10 young men cycled while researchers took muscle and blood samples. Their naturally occurring MOTS-c increased after exercise. The men were not given MOTS-c as treatment. [1]
What does that leave unanswered?
Better performance in treated mice does not establish that injections improve fitness, fatigue or healthy ageing in women. A molecule rising after exercise also does not mean taking it reproduces exercise’s effects.
This paper gives researchers a reason to keep investigating. It does not establish a substitute for exercise, a longer human lifespan or a treatment recommendation.
The human group was small and entirely male. The authors also disclosed consultancy and shareholding interests involving CohBar. [1]
I want to see the whole picture
The encouraging findings belong beside experiments asking different questions, including less encouraging results. Our June 2026 cell-repair article is a useful companion because activating a pathway did not deliver the hoped-for repair.
To answer a human treatment question, we need the relevant intervention tested in people, with meaningful benefits and enough safety follow-up. A compelling biological explanation cannot fill in those missing steps.
Keep exploring the series
The other articles look at a menopause-related mouse model, exercise research involving women and that newer cell-repair finding. Together, they help me understand why MOTS-c is being studied without pretending its possible benefits are already established.
Read the original source
- Reynolds and colleagues: MOTS-c, exercise and age-dependent physical decline ↗Nature Communications · 20 January 2021 · Published abstract, figure descriptions and disclosures reviewed; full paper not independently assessed here. Journal article ↗.